Drreddys Laboratories reported INR72.29B in Debt for its fiscal quarter ending in September of 2026.





Debt Change Date
ANI Pharmaceuticals USD 607.23M 3.26M Sep/2026
Aurora Cannabis CAD 22.68M 1.18M Jun/2026
Bayer EUR 36.45B 2.93B Dec/2025
Canopy Growth CAD 277.33M 1.38M Jun/2026
Cipla INR 6.99B 857M Sep/2026
Corcept Therapeutics USD 8.99M 430K Sep/2026
Drreddys Laboratories INR 72.29B 5.05B Sep/2026
GlaxoSmithKline GBP 18.24B 818M Jun/2026
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Lonza CHF 4.71B 915M Dec/2024
Novartis USD 49.01B 2.02B Jun/2026
Pacira USD 293.59M 69.53M Sep/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 2.07B 1.02B Jun/2026
Richter Gedeon HUF 21.74B 1.93B Dec/2024
Sun Pharmaceuticals INR 46.27B 22.65B Mar/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Teva Pharmaceutical Industries USD 16.98B 110M Sep/2026